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SUMMARY
 
CD4
 
+
 
 T cells respond to antigen immunization through a
process of activation, clonal expansion to generate activated
effector T cells followed by activation-induced clonal deletion
of the responding T cells. While loss of responding T cells in
post-activation death by apoptosis is a major factor regulating
immune homeostasis, the precise pathways involved in down-
sizing of 
 
Plasmodium falciparum
 
 antigen-induced T cell
expansions are not well characterized. We report in this study
that splenic CD4
 
+
 
 T cells from mice immunized with non-
replicating immunogens like OVA or recombinant blood stage
 
P. falciparum
 
 antigens, PfMSP-3 and PfMSP-1
 
19
 
 or crude
parasite antigen (PfAg) undergo sequential T cell activation,
proliferation followed by activation-induced cell death (AICD)
in a dose- and time-dependent manner after Ag restimulation.
While PfMSP-3 and OVA-induced AICD was mediated through
a death receptor-dependent apoptotic program, PfMSP-1
 
19
 
and PfAg-induced AICD was via a mechanism dependent on
the activation of mitochondria apoptosis signalling pathway
through Bax activation. These results provide insights into the
mechanism through which two blood stage merozoite antigens
trigger different apoptotic programs of AICD in splenic CD4
 
+
 
T cells.
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INTRODUCTION
 
CD4
 
+
 
 T cells respond to foreign antigen by becoming activ-
ated proliferating effector cells and after clonal expansion,
majority of the effector cells die by apoptosis. Apoptotic cell
death is an important mechanism for maintaining homeo-
stasis in the T cell compartment and regulating the fates
of T cells following encounters with foreign antigens. The
majority of activated T cells undergo activation-induced cell
death (AICD), in which activation through the TCR with
antigen or polyclonal activators (e.g. superantigens) results
in apoptosis (1). CD4
 
+
 
 T cell death is also determined by a
number of factors such as the nature and intensity of TCR
signalling, lack of costimulation, the availability of cytokines
or aberration in the cell cycle program (1–4).
Several studies have revealed two major apoptotic path-
ways, the extrinsic death receptor pathway and the intrinsic
mitochondrial pathway that control apoptosis of CD4
 
+
 
 T
cell (4,5). Ligation of death receptors (such as Fas, TNFR1,
DR3, DR4 and DR5) with their respective ligands convey
apoptotic signals to adaptor molecules that recruit and activate
a family of cysteine proteases, caspases. Activation of caspases
lead to a cascade of molecular events that result in biochemical
as well as morphologic alterations associated with programmed
cell death (6–10). In the second death pathway, mitochondrial
dysfunction plays a central role in commitment of cells to apo-
ptosis (11). The mitochondrial death pathway is characterized
by a decrease in mitochondrial transmembrane potential, release
of apoptogenic proteins such as cytochrome c and apoptosis-
inducing factor (AIF) and the activation of caspases (12).
Members of the Bcl-2 family of proteins regulate the changes
in the mitochondrial membrane permeability and in the
release of apoptogenic factors (13,14).
Immunity to asexual blood stage malaria is dependent on
both humoral as well as cellular immune responses (15–17).
Recent studies suggest that malaria parasites may actually
modulate or even exploit the host immune responses to facilitate
its survival in an antagonistic environment (18–20). Cellular
immune responses may be initiated against merozoites antigens
subsequent to phagocytosis and processing of infected red
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blood cells, free merozoites or cellular debris. CD4
 
+
 
 T cells
dictate the quality and the fate of the protective immune
responses to asexual blood stage malaria in both human as
well as murine models (21–23). The acute malaria infection
is associated with defects in cellular immune responses that
have been attributed to alterations in the T cell functions.
 
Plasmodium
 
 parasite may have developed apoptosis of
T cells as an evasive mechanism to suppress the efficiency
of host’s immune system to control infection. Some studies
have shown that PBL obtained from patients during acute
blood stage infection fails to respond to antigens derived
from malaria parasites or to mitogen while others have
shown that there were no differences in the response to
mitogenic stimulation of PBMC from infected patients and
controls (24–28). Also, during malaria infection a proportion
of the lymphocyte population were found to be sensitive to
apoptosis but only after an interval of  time before 
 
in vivo
 
activated cells would express the apoptotic process 
 
in vitro
 
(28–31). Apoptosis was found to be significantly increased
in the CD4 T cell subset compared to CD8 and 
 
γδ
 
 T cells in
 
Plasmodium falciparum
 
 infected patients and contributed to
the low frequency and number of CD4
 
+
 
 
 
T cells in the peripheral
circulation during active disease (32,33).
The blood stage merozoites express a number of surface
antigens that are involved in the initial interaction between
the parasite and the host erythrocytes (34). These antigens
act both as targets for the immune response and as negative
regulators of host immunity (35). Merozoite surface protein-
1 (MSP-1) and MSP-3 are both involved in the development
of protective humoral immunity against malaria infection.
MSP-1 undergoes a series of proteolytic cleavages resulting
in the highly conserved 19 kDa carboxy-terminal fragment,
PfMSP-1
 
19
 
, which is associated with the merozoite during
the invasion (36,37). Several studies have provided evidences
suggesting that the MSP-1
 
19
 
 is the target of protective im-
munity against asexual blood stages of malaria parasites
(36,37). MSP-3 is a 48-kDa molecule of unknown function
associated with the merozoite surface (38,39). MSP3-specific
cytophilic antibodies are effective in controlling parasite
multiplication by the antibody-dependent cellular inhibition
mechanism (39,40). Recent murine malaria models have shown
that the parasite-specific as well as 19-kDa carboxyl-terminal
fragment of 
 
P. yoelli
 
 MSP-1 (PyMSP-1
 
19
 
-specific CD4
 
+
 
 T cells)
were depleted after infection with both lethal and nonlethal
species of rodent 
 
Plasmodium
 
 and this deletion significantly
affected the protective immunity to malaria (41,42). How-
ever, still remaining unclear is the pathway(s) through which
the parasite or parasite-antigen induces apoptosis of CD4
 
+
 
T cells during blood stage malaria infection. Identifying the
molecular mechanisms involved in the apoptosis of  CD4
 
+
 
T cells would be relevant to understanding of the malaria
immunity and, in particular, to malaria vaccine research.
In this study we sought to determine the fate of CD4
 
+
 
 T
cells in mice immunized with increasing doses of two re-
combinant MSPs, PfMSP-1
 
19
 
 and PfMSP-3 and crude
 
P. falciparum 
 
antigen (PfAg). We found that PfMSP-1
 
19
 
 and
PfMSP-3 as well as PfAg sensitize mouse splenic CD4
 
+
 
 T
cells sequentially to activation, proliferation followed by AICD
through distinct apoptotic program. Our study demonstrates
that apoptosis induced in CD4
 
+
 
 T cells by PfMSP-3 is Fas
mediated and involved activation of caspase-8 and -3 whereas
PfMSP-1
 
19
 
 and PfAg enhanced AICD via a mechanism
dependent on the activation of  mitochondrial apoptosis
signalling pathway involving changes in Bcl-2 : Bax ratio
and the release of cytochrome c and activation of caspase-9.
 
MATERIALS AND METHODS
 
Mice
 
Female BALB/c (H-2
 
d)
 
 mice aged 8–10 weeks were purchased
from The Jackson Laboratory (Bar Harbor, ME) and
maintained in the pathogen-free small animal facility of
the International Centre of Genetic Engineering and Bio-
technology (New Delhi, India). All animal experimentations
were done in accordance to the protocols approved by the
Institutional Animal Ethics Committee (IAEC).
 
Antigens
 
Gene for PfMSP-3 full protein (PfMSP-3) and synthetic gene
for 19 kDa fragment of PfMSP-1 designed based on codon
bistable of 
 
Escherichia coli
 
, were cloned into the expression
vector pET28a(
 
+
 
) (Novagene) and transformed into 
 
E. coli
 
BLR (DE3) host cells. Expression of  the recombinant
PfMSP-3 and PfMSP-1
 
19
 
 were induced with 1 m
 
m
 
 isopropyl-
 
β
 
-
 
d
 
-thiogalactopyranoside (IPTG) (Sigma-Aldrich, St. Louis,
MO). For the purification of  PfMSP-3 and PfMSP-1
 
19
 
proteins, the induced pellets were sonicated and the recom-
binant protein present in the soluble fraction was purified
by metal affinity chromatography using nickel–NTA-matrix
(Qiagen, Valencia, CA). Purified recombinant PfMSP-3 and
PfMSP-1
 
19
 
 were analysed for purity and homogeneity by
sodium dodecyl sulphate (SDS)–polyacrylamide gel electro-
phoresis (PAGE) and reverse-phase chromatography. Mass
spectrum analysis and N-terminal sequencing confirmed the
molecular identity of the purified PfMSP-3 and PfMSP-1
 
19
 
.
The protein preparations contained 
 
<
 
 2 endotoxin units per
mg of protein. To prepare crude parasite antigen (PfAg),
mature schizonts of 
 
P. falciparum
 
 parasites of the 3D7 strain
were harvested from synchronized cultures of 10% parasitaemia
by centrifugation through 60% Percoll gradients (Sigma).
Schizont-infected erythrocytes were washed three times in
serum-free medium to remove endogenous serum proteases
 © 2008 The Authors
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and other proteins. The parasites (10
 
8
 
/mL) were lysed with
0·01% saponin/PBS at 4
 
°
 
C for 10 min followed by sonica-
tion in the presence of protease inhibitors (Sigma). After
sonication, the lysate was centrifuged at 14 000
 
 g
 
 for 30 min
at 4
 
°
 
C. The protein concentration was determined by
bicinchoninic acid (BCA) assay (Pierce, Rockford, IL). As
nonmalaria antigen, ovalbumin (OVA) (Sigma) was used.
 
Immunizations
 
A total of 6–8 BALB/c mice per group were treated sub-
cutaneously with phosphate buffered saline (PBS), or 25, 50
or 100 
 
μ
 
g of recombinant MSP-1
 
19
 
, PfMSP-3F, PfAg or OVA
in CFA and boosted 2 weeks later with same amount of antigen
in IFA. 7 days after boosting, splenic CD4
 
+
 
 
 
T cells were purified
from these mice and used as primed cells. Splenic CD4
 
+
 
 
 
T cells
from adjuvant control mice were used as unprimed cells.
 
Purification of CD4
 
+
 
 
 
T cells and antigen-presenting cells 
(APCs) from spleen and stimulation
 
Unprimed and antigen primed CD4
 
+
 
 
 
T cells were purified
from spleens with the MACS CD4 Multisort Kit (Miltenyi
Biotech, Auburn, CA). The purity of the CD4 cells (95–
98%) was confirmed by flow cytometric analysis using anti-
CD4 antibodies (BD PharMingen, San Diego, CA). APCs
were purified using anti-MHC II beads (MACS, Miltenyi
Biotech) from spleens of naive syngenic mice. In total, 5 
 
×
 
10
 
5 
 
purified CD4
 
+
 
 
 
T cells from primed mice were cultured
with medium alone, or titrated dose of PfMSP-1
 
19
 
, PfMSP-
3, PfAg or anti-CD3e antibodies in the presence of 1 
 
×
 
 10
 
6
 
splenic APCs at 37
 
°
 
C in a 5% CO
 
2
 
 atmosphere for 24–96 h
in RPMI-1640 (Invitrogen Life Technologies, Grand Island,
NY) supplemented with 10% fetal bovine serum (Invitro-
gen), 2 m
 
m
 
 glutamine, 10 m
 
m
 
 HEPES, 50 
 
μ
 
m
 
 2-ME, 0·1 mg/
mL streptomycin and 100 U/mL penicillin. Cells were
pulsed with 1·0 
 
μ
 
Ci/well of [
 
3
 
H]thymidine during the last
16 h of culture and labelled cells were harvested and
counted by liquid scintillation (Betaplate; Wallac, Turku,
Finland). Data are expressed as mean counts per minute (cpm)
of triplicate cultures. SEM was 
 
<
 
 20% of the mean values.
To delineate the AICD pathway, activated CD4
 
+
 
 
 
T cells
were pretreated with 10 
 
μ
 
g/mL of various soluble decoy pro-
teins such as human Fas–Fc immunoglobulin fusion protein
(binds CD95L and blocks the receptor-ligand interaction),
TNFR.Fc (binds TNF and blocks the receptor-ligand inter-
action), TRAIL.Fc (binds TRAIL and blocks the receptor–
ligand interaction), or 50 
 
μ
 
m
 
 of  pan specific caspase inhi-
bitor, caspase-3 inhibitor, caspase-8 inhibitor and caspase-9
inhibitor (all from R&D Systems Inc., Minneapolis, MN) for
1 h. Caspase inhibitors were dissolved in DMSO and control
cultures were performed in the presence of diluted DMSO,
dilution not exceeding 0·1%. Cells were then stimulated with
recall antigen and splenic APCs in the absence or presence
of soluble decoy proteins or different caspase inhibitors for
72 h, and thereafter CD4 T cell death was measured.
 
Flow cytometry analysis of apoptotic cells and expression 
of apoptotic regulatory markers
 
Apoptosis was measured by three-colour flow cytometry.
A total of  1 
 
×
 
 10
 
6 
 
splenocytes were stained with cychrome-
conjugated CD4 and PE conjugated CD44 for 30 min on ice.
Cells were washed with PBS and stained with FITC labelled
annexin V (BD PharMingen). After incubation for 15 min at
room temperature in the dark cells were immediately ana-
lysed on a FACSCaliber flow cytometer (BD Immunocyto-
metry System, San Jose, CA). For the detection of T cells
activation markers and expression of apoptotic regulatory
molecules, cells were stained with indicated Abs in PBS sup-
plemented with 1% FCS and 0·1% sodium azide for 30 min
on ice. Cells were then washed and analysed on a BD
Biosciences FACSCalibur. The following conjugated Abs
(from BD Pharmingen) were used for flow cytometric analyses:
anti-CD4 PE, anti-CD4 Cychrome, anti-CD44 PE, anti-
CD62L FITC, anti-CD69 FITC, anti-CD25 PE anti-
CD45RB FITC, anti-Fas PE, anti-FasL PE. For intracellular
staining for Bcl-2 family members, cells were surface stained
as described above, fixed with 1% paraformaldehyde for
30 min, washed twice in permeabilization buffer (PBS with
0·3% saponin, 1% FCS, and 0·1% sodium azide) fixed with
1% paraformaldehyde and then stained with either hamster
anti-Bcl-2 mAb (PharMingen) or rabbit anti-Bax Ab (R&D
System), followed by either FITC-labelled goat antihamster
IgG Ab (eBioscience, San Diego, CA) or goat antirabbit
IgG Ab (Sigma) diluted in permeabilization buffer and all
incubations were of 40-min duration on ice. Isotype matched
FITC/PE tagged controls (eBioscience) were included with
each set. Cells were resuspended in saponin-free buffer. At
least 30 000 cells were acquired on a BD FACSCalibur flow
cytometer (BD Biosciences) and the data was analysed with
FlowJo software (Treestar, San Jose, CA).
 
Preparation of cell lysates and subcellular fractionation
 
Stimulated CD4
 
+
 
 
 
T cells (2 
 
×
 
 10
 
6 
 
cells) were washed twice
with chilled PBS and lysed by suspending the cells in 50 
 
μ
 
L
of Triton X-100 lysis buffer (30 m
 
m
 
 Tris–HCl, pH7·5,
150 m
 
m
 
 NaCl, 2 m
 
m
 
 EDTA, 1 m
 
m
 
 PMSF and 10 
 
μ
 
g/mL of
peptide inhibitors leupeptin, pepstatin, aprotinin 1% Triton
X-100 and 10% glycerol on ice for 30 min, followed by
centrifugation at 14 000
 
 g
 
 at 4
 
°
 
C for 15 min. The subcellular
fractionation of CD4
 
+
 
 
 
T cells was according to the published
protocol (32). Simulated CD4
 
+
 
 
 
T cells (2 
 
×
 
 10
 
6 
 
cells) were
washed twice with ice-cold PBS and resuspended in 100 
 
μ
 
L
digitonin lysis buffer containing 190 
 
μ
 
g/mL of digitonin,
 500
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250 m
 
m
 
 sucrose, 8 m
 
m
 
 Na
 
2
 
HPO
 
4
 
, 1 m
 
m
 
 NaH
 
2
 
PO4 75 mm
NaCl, 1 mm PMSF, and 10 μg/mL of protease inhibitors
aprotitin, pepstatin, and leupeptin. After 5 min incubation
at 4°C, cells were centrifuged at 14 000 g for 5 min at 4°C.
The resulting supernatant was transferred to a fresh tube
designated as cytosol. The pellet was resuspended in 0·1%
Triton X-100 lysis buffer (25 mm Tris–HCl buffer (pH 8·0),
0·1% Triton X-100) and designated as mitochondrial
fraction. Protein concentration in the cell lyaste and sub-
cellular fractions were measured by bicinchoninic acid
(Pierce) protein assay.
Western blotting
For Western blot detection of proteins, cell lysates or sub-
cellular fractions equivalent to 2 × 106 cells were boiled for
5 min in 50 μL of 2 × Laemmli buffer. A measure of 20 μL
of the samples were resolved (2 × 106/lane) on 10%, 12% or
15% SDS-PAGE gels depending on the protein being detected.
After electrophoresis proteins were transferred to Hybond
nitrocellulose membrane (Amersham Bioscience, Piscataway,
NJ) and blocked with 5% milk in phosphate-buffered saline
with 0·05% Tween-20 (Sigma) overnight at 4°C. Membranes
were washed with PBS/Tween and then incubated with anti-
Bax and anti-cytochrome c (from PharMingen). The blots were
washed with PBS/Tween and developed with horseradish-
peroxidase conjugated secondary antibodies in 0·1% milk
PBS/Tween. Western blots were developed using enhance
chemiluminescence kit (Amersham Bioscience).
Caspase colourimetric assay
Antigen primed CD4+ T cells were not treated or pretreated
with 10 μg/mL of various soluble decoy proteins such as
human Fas–Fc immunoglobulin fusion protein or 50 μm
of caspase-3 inhibitor, caspase-8 inhibitor and caspase-9
inhibitor. Cells were then stimulated with recall antigen and
splenic APCs in the absence or presence of  Fas-Fc or dif-
ferent caspase inhibitors for 96 h, and thereafter caspase-8,
caspase9 and caspase-3 activity was measured by a colouri-
metric assay according to the manufacturer’s instructions
(R&D System). Briefly, 2 × 106 cells were lysed and the
lysate was tested for cleavage of IETD-pNA, LEDH-pNA
and DEVD-pNA, substrate for caspase-8, caspase9 and
caspase-3, respectively, and the results were expressed as
absorbance at 405 nm.
Statistics
Statistical significance was calculated by a 2-sample 2-tailed
Student’s t-test (GraphPad InStat). Comparisons were
considered statistically significant at P < 0·05.
RESULTS
Proliferative response of PfMSP-119 or PfMSP-3 primed 
CD4+ T cells
In the present study we examined the effects of recombinant
P. falciparum antigens on proliferation, clonal expansion,
and apoptosis of splenic CD4+ T cells in vitro. In initial
experiments, mice were immunized with increasing dose
(25, 50 or 100 μg) of PfMSP-119, PfMSP-3 or crude PfAg and
OVA (OVA was used as nonmalarial antigen) twice in CFA/
IFA and 7 days after the last immunization, splenic CD4+
T cells were stimulated in vitro with various doses of recall
antigen plus APCs. Ex vivo CD4+ T cells from mice
immunized with 25, 50 or 100 μg of PfMSP-119 PfMSP-3,
PfAg or OVA revealed a highly activated phenotype with
up-regulated levels of CD25, CD44 and CD69 expression
and reduced levels of CD62L and CD45RB compared to
adjuvant control mice (Table 1). However, irrespective of the
antigen dose, CD4+ T cells from immunized mice showed
heterogeneous proliferative responses to recall antigen or
anti-CD3. CD4+ T cells from mice immunized with 25, 50 or
100 μg of PfMSP-119 demonstrated considerably decreased
proliferative responses when stimulated with titrated dose of
recall antigen or anti-CD3 (Figure 1a). Similar results were
obtained with splenic CD4+ T cells from mice primed with
PfAg (Figure 1a). In contrast, the proliferative responses of
CD4+ T cells from PfMSP-3 or OVA immune mice increased
with increasing Ag doses administered to mice (25, 50 or
100 μg), but the increased response seen after high dose
PfMSP-3 was not significant (P = 0·21) (Figure 1a). In case
of OVA, high dose (100 μg) showed significant increase in the
proliferative response compared to 25 μg (P < 0·05) (Figure 1a).
CD4+ T cells purified from various antigen primed mice
failed to respond to heterologous antigen stimulation (data
not shown). CD4+ T cells purified from adjuvant control
mice proliferated in response to anti-CD3 stimulation but
not in response to malaria antigens or OVA (Figure 2a).
Further, in the absence of splenic APCs, antigen-primed
CD4+ T cells showed no proliferative response to recall anti-
gen even at high antigen dose (Figure 2b), indicating that
recombinant malaria antigens did not have mitogenic effect
on CD4+ T cells and that accessory cells are essential for the
induction of T-cell proliferation.
Comparing the proliferative response between various
antigen primed CD4+ T cells, PfMSP-3 primed CD4+ T cells
showed enhanced proliferation compared with PfMSP-119-
or PfAg-primed CD4+ T cells after stimulation with anti-
CD3 irrespective of the priming dose (Figure 2c). However,
CD4+ T cells from OVA-primed mice showed significant
proliferation in response to anti-CD3 stimulation compared
to PfMSP-3 primed CD4+ T cells (P < 0·01) and PfMSP-119-
© 2008 The Authors 501
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Figure 1 Proliferative activity of CD4+ T 
cells from mice primed with PfMSP-119 and 
PfMSP-3. Mice were administered twice with 
increasing dose of recombinant PfMSP-119, 
PfMSP-3, crude P. falciparum antigen (PfAg), 
control antigen OVA (25, 50 and 100 μg per 
mouse) or PBS in CFA/IFA. Cultures were 
set up 7 days after last immunization. 
Proliferative responses of purified CD4+ T 
cells from the spleen of the immune mice in 
the presence of syngenic splenic APCs are 
represented as counts per minute of 
[3H]thymidine incorporation in triplicate 
cultures in response to titrating doses of recall 
antigen in vitro (left panels) and as the 
stimulation index determined by dividing the 
mean experimental proliferation value by the 
mean of the medium control proliferation 
value at a representative (100 μg/mL) dose of 
recall antigen (right panels). Background 
levels of [3H]thymidine incorporation in the 
absence of antigenic stimulation were 
1250–2500 cpm. The results are representative 
of three experiments. Statistical significance 
for each group is indicated above the bars. NS, 
not significant.
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Figure 2 Proliferative activity of CD4+ T cells from adjuvant control mice or antigen primed mice following antigen or polyclonal stimulation. 
Mice were administered twice with increasing dose of recombinant PfMSP-119, PfMSP-3, crude P. falciparum antigen (PfAg), control antigen 
OVA (25, 50 and 100 μg per mouse) or PBS in CFA/IFA. Cultures were set up 7 days after last immunization. (a) Proliferative responses of 
purified CD4+ T cells from the spleen of the adjuvant control mice in the presence of syngenic splenic APCs in response to (100 μg/mL) dose 
of recall antigen. The proliferative responses are given as a stimulation index determined by dividing the mean experimental proliferation value 
by the mean of the medium control proliferation value. (b) Proliferative responses of purified CD4+ T cells from the spleen of the antigen 
primed mice in the absence of syngenic splenic APCs in response to two doses of recall antigen (1 and 100 μg/mL) and10 μg/mL of anti-CD3 
antibodies. The proliferation values are given as a stimulation index determined by dividing the mean experimental proliferation value by the 
mean of the medium control proliferation value. (c) Proliferative responses of purified CD4+ T cells from the spleen of mice primed with 
increasing dose of antigen in the presence of splenic APCs in response to 1 μg/mL of anti-CD3 antibodies. The proliferative responses are given 
as a stimulation index determined by dividing the mean experimental proliferation value by the mean of the medium control proliferation 
value. Data are representative of those from three experiments. Statistical significance for each group is indicated above the bars. (d) Purified 
CD4+ T cells from the spleen of mice primed with 50 μg antigen were stimulated with 100 μg/mL of recall antigen in the presence of syngenic 
splenic APCS and T cell proliferation was assayed at the times indicated. Data are represented as mean ± SE of counts per minute and are 
representative of two independent experiments.
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or PfAg-primed CD4+ T cells (P < 0·001) (Figure 2c).
Furthermore, the reduced proliferation observed in PfMSP-
119- or PfAg-primed CD4
+ T cells was not due to a higher
activation threshold because high concentrations of anti-
CD3 stimulation (1 μg/mL) did not restore the impairment
in proliferation in PfMSP-119- or PfAg-primed CD4
+ T cells
(Figure 2a).
Time-kinetic analysis of mice immunized with 50 μg of
antigen further provided evidence that up to 24 h there was
comparable proliferation of PfMSP-119, PfAg and PfMSP-
3-primed CD4+ T cells, but significantly increased prolifera-
tion was evident by 72 h of PfMSP-3- and also OVA-primed
CD4+ T cells (Figure 2d). Noticeably, proliferation in PfMSP-
119-primed as well as PfAg-primed CD4
+ T cell declined
more rapidly than PfMSP-3-and OVA-primed CD4+ T cells,
reaching baseline levels by 96 h after stimulation (Figure 3a).
After 96 h of  in vitro culture, CD4+ T cells from PfMSP-3
or OVA primed mice also displayed notable reduction in
proliferative responses (Figure 2d). Irrespective of  their
proliferative response, PfMSP-119, PfMSP-3, PfAg or
OVA-primed CD4+ T cells after recall stimulation induced a
large population of activated CD4+ T cells and expressed sur-
face markers characteristic of effector T cells: CD4+CD44high
CD62Llow that was not evident in adjuvant control group
(Figure 3).
Cell cycle progression in PfMSP-119 and PfMSP-3 
primed CD4+ T cells
Since activated PfMSP-119 and PfAg-primed CD4
+ T cells
showed poor proliferating response following recall or anti-
CD3 stimulation, we examined the expression of prolifera-
tion marker Ki-67, an indicator of cell cycle progression that
is not expressed by the resting cells but increases in late G1
phase of the cell cycle indicating ongoing proliferation (43).
A small proportion of ex vivo CD4+ T cells isolated from mice
administered different doses of antigen expressed low but
readily detectable levels of Ki-67, thus showing signs of
active cell cycling at this time point (0 h) (Figure 4a). After
24 h of stimulation with recall antigen in vitro, there was a
modest increase in the percentage of Ki-67 positive cells in
PfMSP-119 and PfAg primed CD4
+ T cells indicating active
cellular multiplication (Figure 4a). But after 48 h of stimu-
lation, there was a progressive and marked decline in the
percentage of Ki-67-positive cells (Figure 4a). These data
indicate that the failure of PfMSP-119 and PfAg-primed
CD4+ T cells to proliferate in the presence of recall antigen
results from a block in cell cycle progression. In contrast,
in PfMSP-3 and OVA primed CD4+ T cells, there was an
increase in the percentage of Ki-67 positive cells till 72 h of
stimulation indicating that the cells were in active cell cycle
phases. However, after 96 h of stimulation, percentage ofTa
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Ki-67 positive cells within PfMSP-3 and OVA-primed CD4+
T cells decreased considerably marking the end of  the
proliferation phase (Figure 4a).
AICD of PfMSP-119 or PfMSP-3 primed CD4
+ T cells
We next determined whether the arrest of antigen-primed
CD4+ T cell proliferation observed following recall stimula-
tion was due to increased T cell death. To address this issue,
we determined the proportion of cells undergoing apoptosis
in each of the activated antigen primed CD4+ T cell by
simultaneous annexin V, CD4 and CD44 staining. All four
antigens used in the study (PfMSP-119, PfAg, PfMSP-3 and
also OVA) induced cell death in antigen primed CD4+ T
cells in a time- and dose-dependent manner during in vitro
stimulation with recall antigen (Figure 4b). The percentage
of  apoptotic cells in Ag primed CD4+ T cells increased in
a dose-dependent manner. PfAg and PfMSP-119 primed
CD4+ T cells showed maximal apoptotic cells (18% and
12%, respectively) at 100 μg/mL whereas PfMSP-3 and OVA
primed CD4+ T cells showed maximum annexin V+ cells (7%
and 6%, respectively) at 300–1000 μg/mL of recall antigen
(Figure 4b). When purified CD4+ T cells from mice primed
with increasing antigen dose were co-cultured with APCs
and recall antigen at 100 μg/mL, there was an increase in
antigen-induced death with increasing priming dose from 25
to 50 μg (P < 0·05), but there was no marked increase in
apoptotic CD4+ T cells when dose was increased from 50
to 100 μg in various antigen groups (Figure 4c). Culturing
different antigen primed CD4+ T cells with heterologous
antigen plus APCs caused < 1% apoptosis in CD4+ cells,
indicating antigen specific response (data not shown). No
AICD was induced in CD4+ T cells isolated from adjuvant
control mice when stimulated in vitro with PfMSP-119,
PfMSP-3 or OVA indicating that these antigen preparations
were not toxic to cells (Figure 4).
In time kinetic, at 24 h, the percentage of  annexin V
positive CD4+ T cells was similar for PfMSP-119, PfAg and
PfMSP-3 activated CD4+ T cells (Figure 4c). However by
48 h, the PfMSP-119- and PfAg-activated CD4
+ T cells showed
a greater percentage of annexin V positive cells that were
more pronounced at 72 and 96 h compared to PfMSP-3-
activated CD4+ T cells (Figure 4c). It was also observed that
compared to OVA-activated CD4+ T cells, percentage of
annexin V positive cells was higher amongst the malaria
antigen primed CD4+ T cells. These results suggest that the
Figure 3 Activated phenotype of CD4+ T cells from mice primed with PfSMP-119 and PfMSP-3. Purified CD4
+ T cells from the spleen of mice 
primed with 50 μg of PfMSP-119, PfAg, PfMSP-3, OVA or PBS in CFA/IFA were stimulated with 100 μg/mL of recall Ag in the presence of 
syngenic splenic APCS. 72 h after stimulation, cells were stained with anti-CD4 vs. anti-CD62L or anti-CD44 to detect activated phenotype. 
The CD62L and CD44 profiles of the gated CD4+ T cells are shown as single-colour histograms. The grey thin line represent isotype control, 
grey filled histogram represent staining on cells from adjuvant control and thick black lines indicate staining on antigen stimulated cells. Data 
are representative of three independent experiments.
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low proliferative responses of PfMSP-119 and PfAg-primed
CD4+ T cells results from a block in cell cycle progression
and increased AICD. In contrast, PfMSP-3 and also OVA
primed CD4+ T cells were able to enter the cell cycle after
recall stimulation and susceptibility to AICD was delayed
till 96 h. After 96 h of antigen stimulation, there was marked
increase in the number of apoptotic cells, a time period that
correlated with the marked decrease in proliferative response.
We also determined whether apoptosis involved CD4+ or
CD8+ T cells or both and B cells in mice primed with PfMSP-
119, PfMSP-3, PfAg and also OVA. Splenocytes from im-
munized mice were stimulated in vitro with recall antigen for
Figure 4 Cell cycle progression and activation-induced cell death of PfMSP-119 and PfMSP-3 primed CD4
+ T cells. Mice were administered 
twice with increasing dose of recombinant PfMSP-119, PfMSP-3, crude P. falciparum antigen (PfAg), control antigen OVA (25, 50 and 100 μg 
per mouse) or PBS in CFA/IFA. Cultures were set up 7 days after last immunization. (a) Purified CD4+ T cells from the spleen were stimulated 
or not stimulated with 100 μg/mL of recall antigen in the presence of syngenic splenic APCS and expression of Ki-67 positive cells in CD4+ 
T cells were assayed by flow cytometry. Cells were gated on CD4+ T cells and analysed for Ki-67 expression at the times indicated. (b) Purified 
CD4+ T cells from the spleen were stimulated with titrating dose of recall antigen in the presence of syngenic splenic APCS. The percentage 
of apoptotic cells among CD4+ T cells were detected, 72 h after stimulation, by staining cells with Annexin V and analysed by flow cytometry. 
(c) Purified CD4+ T cells from the spleen were stimulated with 100 μg/mL of recall antigen in the presence of syngenic splenic APCS. At 
indicated time after in vitro stimulation with recall Ag, percentage apoptotic cells among CD4+ T cells were detected by staining cells with 
Annexin V and analysed by flow cytometry. Data are representative of three independent experiments.
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72 h and apoptotic cells among various cell populations were
assayed. While majority of the apoptotic cells were T cells (38%),
the proportion of B cells that were apoptotic was less compared
to T cells (12% vs. 38%, respectively) and that of macrophages
and dendritic cells were negligible (< 2·6%). Among T cells,
the CD4+ T cells represented the dominant population that
was apoptotic compared to CD8+ T cells (data not shown).
We also investigated whether AICD of antigen-primed CD4+
T cells is antigen specific. We found that PfMSP-119 failed to
induce apoptosis in PfMSP-3 as well as OVA primed CD4+
T cells and similarly PfMSP-3 failed to induce apoptosis in
PfMSP-119 or OVA primed CD4
+ T cells and OVA failed to
induce apoptosis in PfMSP-119 or PfMSP-3 primed CD4
+ T
cells (data not shown). However PfAg, which is a crude parasite
antigen preparation induced apoptosis in both PfMSP-119
and PfMSP-3 but not in OVA primed CD4+ T cells but only
at 1 mg/mL (data not shown). PfAg-induced AICD was signifi-
cantly lower for CD4+ T cells from PfMSP-3-immunized mice
than from PfMSP-119-immunized mice (data not shown).
We next sought to determine the mechanism of apoptosis in
PfMSP-119, PfAg and PfMSP-3 activated CD4
+ T cells.
Role of death receptor signalling in PfMSP-119 
and PfMSP-3 induced AICD of CD4+ T cells
We next examined the expression of various molecules of the
TNF superfamily that may have played a role in the AICD
of antigen-primed CD4+ T cells. Ex vivo antigen-primed CD4+
T cells expressed increased level of Fas and FasL compared
to cells from adjuvant treated mice (Figure 5a,b). CD4+ T cells
from PfMSP-3 or OVA primed mice after in vitro stimulation
with recall antigen showed a time dependent increase in expres-
sion of Fas and FasL as determined by changes in the percent-
age of positive cells (Figure 5c) and fluorescence intensity
(Figure 5d) relative to cells from adjuvant control group treated
with medium alone. In contrast, no significant changes were
observed in the percentage of Fas and FasL positive cells in
PfMSP-119 and PfAg primed CD4
+ T after in vitro stimulation
with recall antigen (Figure 5c). While there was slight time
dependent increase in the mean fluorescence intensity level
of Fas, the fluorescence intensity of FasL remained unchanged
in PfMSP-119 and PfAg primed CD4
+ T after in vitro stimula-
tion with recall antigen (Figure 5d). Expressions of other
members of TNF family involved in the apoptosis of T cells,
TNFR1, TNFR2, TRAILR1 and TRAILR2 on the surface
of Ag-primed CD4+ T cells were not affected by stimulation
(data not shown).
To determine whether Fas–FasL, TNF–TNFRs or TRAIL–
TRAILRs were involved in AICD, CD4+ T cells from Ag
primed mice were treated with competitive inhibitor of Fas–
FasL TNF–TNFRs or TRAIL–TRAILRs interaction, the
soluble Fas.Fc TNFR.Fc or TRAILR.Fc fusion protein,
respectively. Addition of Fas–Fc TNFR.Fc or TRAILR.Fc
fusion protein (10 μg/mL) completely blocked anti-Fas, anti-
TNFR1 and anti-TRAILR1 mediated apoptosis of naïve
CD4+ T cells (data not shown). Treatment with Fas.Fc but not
TNFR.Fc or TRAIL.Fc fusion proteins rescued Ag-primed
CD4+ T cells from PfMSP-3 and also OVA induced apoptosis
(Figure 6). In contrast, addition of the Fas.Fc failed to decrease
levels of PfMSP-119 as well as PfAg induced AICD of CD4
+
T cells (Figure 6), suggesting that Fas–FasL interaction was
not involved in PfMSP-119 or PfAg-mediated apoptosis. Also
TNFR and TRAIL did not play any significant role in the
induction of apoptosis in malaria antigen primed CD4+ T
cells (Figure 6). Together, these results demonstrate that Fas–
FasL interaction account for the AICD of PfMSP-3-as well
as OVA-primed CD4+ T cell but not essential for the induction
of cell death in PfMSP-119 and PfAg-primed CD4
+ T cells
Role of the mitochondrial apoptosis pathway in PfMSP-
119 and PfMSP-3 induced AICD of CD4
+ T cells
It was previously reported that the propensity for activated
T cells to die in the absence of  Fas or TNFR signalling
correlates with a reduction in the Bcl-2 expression relative
to Bax (44–46). We next determined whether PfMSP-119 or
PfMSP-3 induced AICD of CD4+ T cells correlated with
altered expression of anti-apoptotic Bcl-2 and pro-apoptotic
Bax proteins Bax. The expression of pro-apoptotic protein
Bax increased with time in both PfMSP-119 and PfAg
primed CD4+ T cells after in vitro stimulation with recall
antigen (Figure 7a), indicating that increase in Bax level was
probably associated with apoptosis of these antigen primed
CD4+ T cells. The increase in the percentage and MFI of
Bax-containing cells was more prominent in PfAg-primed
CD4+ T cells compared to PfMSP-119-primed CD4
+ T cells
(Figure 7a). While stimulation of antigen primed CD4+ T
cells with recall PfMSP-119 and PfAg drastically increased
the expression of pro-apoptotic Bax, there was no significant
change in the expression of anti-apoptotic Bcl-2 molecule
(Figure 7b). The level of both Bcl-2 and Bax was unaffected
by in vitro stimulation of PfMSP-3 as well as OVA primed
CD4+ T cells with recall antigen (Figure 7a,b). The expres-
sions of other Bcl-2 molecules in Ag-primed CD4+ T cells
remained unchanged after in vitro stimulation with recall
antigen (data not shown). Given that the ratio of Bax : Bcl-
2 determines the susceptibility to cell death rather than the
level of individual protein (45), we calculated the Bax : Bcl-2
ratio using the mean fluorescence intensity of Bax and Bcl-2.
Upon stimulation with PfMSP-119 and PfAg but not with
PfMSP-3 there was time dependent increase in Bax : Bcl-2
protein ratios in primed CD4+ T cells (Figure 7c). Further
subcellular fractionation study revealed that pro-apoptotic
Bax was found to be associated with the mitochondrial and
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Figure 5 Expression of CD95 and CD95L on PfMSP-119 and PfMSP-3 primed CD4
+ T cells. Mice were administered twice with increasing 
dose of recombinant PfMSP-119, PfMSP-3, crude P. falciparum antigen (PfAg), control antigen OVA (25, 50 and 100 mg per mouse) or PBS 
in CFA/IFA. (a) At day 7 after last immunization, splenic cells from Ag primed mice as well as from control adjuvant control mice (shaded 
curves) were stained with anti-CD4 vs. anti-CD95 or anti-CD95L. CD4+ T cells were gated, and their levels of CD95 or CD95L are shown as 
single-colour histograms. Thick line represents CD4+ T cells from primed mice, grey filled histogram represents CD4+ T cells from adjuvant 
control mice, and thin grey line represents corresponding isotype-matched control. Data are representative of two to four independent 
experiments. (b, c) CD4+ T cells from Ag primed mice were purified 7 days after last immunization and stimulated or not stimulated in vitro 
with 100 μg/mL of recall antigen plus splenic APC. At indicated time after stimulation, expression of CD95 and CD95L were determined by 
flow cytometry on CD4+ gated cells. (b) Percentages of CD95 and CD95L among splenic CD4+ T cells and (d) and the mean fluorescence 
intensity (MFI) of staining of CD95 and CD95L are shown. MFI value has been corrected for the mean fluorescence intensity obtained with 
an isotype-matched control mAb. Data from five experiments were pooled to obtain the mean ± SD. *, P < 0·01, **, P < 0·001 are the 
statistically significant difference for each group compared to adjuvant control group indicated above the bars.
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not with the cytosolic subcellular fractions of PfMSP-119
and PfAg primed CD4+ T cells (Figure 8). One major con-
sequence of Bax translocation to mitochondria is the release
of cytochrome c. We next assayed for the release of cyto-
chrome c from the mitochondria of PfMSP-119 and PfAg
primed CD4+ T cells. We found that stimulation of PfMSP-
119 and PfAg-primed CD4
+ T cells with recall antigen
induced cytochrome c release from mitochondria into
cytosol, but no cytosolic cytochrome c could be detected in
the PfMSP-3 or OVA-primed CD4+ T cells upon treatment
with recall antigen plus APCs. These results demonstrate that
pro-apoptotic members of the Bcl-2 protein family through
mitochondrial dependent pathway modulated PfMSP-119
and PfAg induced AICD of CD4+ T cells.
AICD of CD4+ T cells induced by recombinant 
Plasmodium falciparum antigens are caspases dependent
Caspases, the central elements of the Fas- and mitochondria-
mediated apoptotic pathways, initiate a cascade of events
that end in death of  the cells (47). To determine whether
caspases were involved, we compared the effect of different
caspase inhibitors on AICD of  CD4+ T cells induced by
different malarial antigens. As shown in Figure 9a, z-VAD-
fmk, a general caspase inhibitor effectively blocked AICD in
antigen primed CD4+ T cells restimulated with recall PfMSP-
119, PfAg, PfMSP-3 or OVA. Stimulation of Ag-primed CD4
+
T cells in the presence of  specific inhibitors of  caspase-3
(z-DEVD-fmk) and caspase-8 (z-IETD-fmk) blocked PfMSP-
3 and also OVA-induced AICD. On the other hand, specific
caspase-9 inhibitor (z-LEHD-fmk) caspase-3 inhibitor (z-
DEVD-fmk) and caspase-8 inhibitor (z-IETD-fmk) had a
strong protective effect against both PfMSP-119- and PfAg-
induced AICD of CD4+ T cells (Figure 9a).
In next set of experiments, we determined the hierarchy of
the caspase cascade in PfMSP-119 and PfMSP-3-induced
AICD of CD4+ T cells. By using an enzymatic colourimetric
assay, we evaluated caspase activity in CD4+ T cell lysates
by using specific fluorescence substrates (Ac-IETD-pNA,
Ac-LEHD-pNA and Ac-DEVD-pNA) in the absence or
presence of caspase inhibitors (Figure 9b). Compared with
CD4+ T cells from adjuvant control mice, CD4+ T cells from
PfMSP-119-, PfMSP-3- PfAg- and OVA-primed mice expressed
increased caspase activation after in vitro stimulation with
recall antigen (Figure 9b). CD4+ T cells from PfMSP-119- and
PfAg-primed mice expressed increased caspase-9, caspase-3
and caspase-8 activities in response to recall stimulation
(Figure 9b). Presence of z-LEHD-fmk during stimulation
prevented activation of all three caspases (caspase-9, caspase-
3 and caspase-8), z-DEVD-fmk prevented activation of both
caspase-3 and caspase-8, whereas the z-IETD-fmk blocked
the activation of caspase-8 only (Figure 9b). Both z-DEVD-
fmk and z-IETD-fmk failed to block the activation of caspase-
9 (Figure 9b). In contrast, CD4+ T cells from PfMSP-3 and
OVA-primed mice expressed increased caspase-8 and caspase-
3 activities upon in vitro stimulation with recall antigen
(Figure 9b). In these cells, presence of z-IETD-fmk during
recall stimulation blocked the activation of both caspase-8
and caspase-3 whereas z-DEVD-fmk blocked the activation
of caspase-3 only (Figure 9b) whereas z-LEHD-fmk had
almost no effect, indicating that caspase-9 activation was
dispensable for AICD of PfMSP-3 and OVA-primed CD4+
T cells.
Since PfMSP-3, PfMSP-119 and PfAg primed CD4
+ T
cells were found to express different levels of Fas and FasL
on the cell surface after stimulation (Figure 5), we deter-
mined whether interference in Fas-FasL interaction affected
caspase activation in these antigen-primed CD4+ T cells.
Caspase enzymatic activity was again determined in the cell
lysates by colourimetric assay (Figure 10). As we had shown
in Figure 6, Fas-Fc inhibited PfMSP-3 as well as OVA-
induced AICD, addition of  soluble Fas–Fc fusion protein
to the culture prevented PfMSP-3-mediated activation of
caspase-8 and caspase-3 (Figure 10). In contrast, Fas-Fc had
Figure 6 Role of death receptor signalling in AICD of PfMSP-119 
and PfMSP-3 primed CD4+ T cells. CD4+ T cells isolated from 
PfMSP-119, PfAg, PfMSP-3, OVA and adjuvant treated mice were 
stimulated or not stimulated in vitro with recall antigen plus splenic 
APCs. Fas–Fc TNFR.Fc or TRAILR.Fc fusion proteins (1 μg/mL) 
were added at the beginning of the culture and maintained 
throughout the culture. After 72 h, percentage of apoptotic cells 
among CD4+ T cells were detected by staining cells with Annexin V 
FITC and analysed by flow cytometry. Data from five experiments 
were pooled to obtain the mean ± SD. *, P < 0·02 is the statistically 
significant difference indicated above the bars.
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little effect on the AICD of CD4+ T cells induced by PfMSP-
119 or PfAg (Figure 6). Consistent with these results, addi-
tion of Fas.Fc fusion protein in the culture medium had little
effect on the activation of caspase-9, caspase-8 and caspase-
3 in CD4+ T cells stimulated PfMSP-119 or PfAg (Figure 10).
These results indicate that PfMSP-119 and also PfAg induced
AICD of CD4+ T cells was via the mitochondrial death
pathway while PfMSP-3 and OVA induced AICD of CD4+
T cells depended on the Fas–FasL interactions. Our data
demonstrate that different P. falciparum merozoite surface
antigens can trigger diverse programs of  AICD in CD4+
T cells.
DISCUSSION
In this study we sought to determine the fate of CD4+ T cells
(proliferation and activation induced cell death) in mice im-
munized with the blood stage recombinant merozoite surface
antigens, PfMSP-119 and PfMSP-3 and the molecular events
underlying the process of AICD of antigen primed CD4+ T
cells. It has been established that in response to infection or
immunization, Ag-reactive responses are normally related
with the proliferation of Ag-specific T cells that differentiate
Figure 7 Expression of Bcl-2 and Bax on 
PfMSP-119 and PfMSP-3 primed CD4
+ T 
cells. CD4+ T cells from Ag primed mice were 
purified 7 days after last immunization and 
stimulated or not stimulated in vitro with 
100 μg/mL of recall antigen plus splenic 
APC. At indicated time after stimulation, 
intracellular expression of Bax and Bcl-2 
were determined by flow cytometry on CD4+ 
CD44+ gated cells. (b) Percentages of Bax 
and Bcl-2 among splenic CD4+ T cells and 
(c) and the mean fluorescence intensity (MFI) 
of staining of Bax and Bcl-2 are shown. MFI 
value has been corrected for the mean 
fluorescence intensity obtained with an 
isotype-matched control mAb. Data from five 
experiments were pooled to obtain the 
mean ± SD. *, P < 0·01 is the statistically 
significant difference for each group 
compared to adjuvant control group indicated 
above the bars. C, At indicated time after 
in vitro stimulation with recall Ag, ratio of 
Bax : Bcl-2 protein expression (fluorescence 
intensity) among various antigens primed 
CD4+ T cells was calculated. Data from three 
experiments were pooled to obtain the 
mean ± SD. *, P < 0·01, **, P < 0·001 are the 
statistically significant difference for each 
group compared to adjuvant control group 
indicated above the bars.
Figure 8 Movement of Bax or cytochrome c to or from 
mitochondria in PfMSP-119 and PfMSP-3 primed CD4
+ T cells. 
CD4+ T cells from Ag primed mice were purified 7 days after last 
immunization and stimulated or not stimulated in vitro with 100 μg/
mL of recall antigen plus splenic APC. CD4+ T cells were harvested, 
72 h after stimulation, and cytosolic and mitochondrial Bax and 
cytochrome c levels were determined by Western blot analysis. 
Markers for the respective fractions of mitochondria (CoxIV) and 
cytosol (β-actin) are also shown. Results are representative of two 
independent experiments.
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to an effector phenotype (2). This oligoclonal expansion of
T cells is counterbalanced by apoptotic cell death of the
activated CD4 T cells upon restimulation (1,3). This form of
apoptosis, called AICD is an active cell suicide mechanism
of widespread biological importance that constitutes the
physiological response of  normal T cells to activation and
is believed to control the number of Ag-stimulated T cells
during the immune response. Our in vitro results extend
these findings by demonstrating that during immunization
with nonreplicating immunogens like OVA or recombinant
P. falciparum blood stage antigens, activated CD4+ T cells
when restimulated with Ag through TCR undergo AICD.
CD4+ T cells from mice primed with increasing dose of
PfMSP-119, PfMSP-3, crude parasite antigen (PfAg) as well
as OVA-primed show activated phenotype and expressed
high levels of the acute activation markers CD69, CD25 as
well as CD44 and decrease CD62L and CD45RB expression
on the cell surface. Despite activated phenotype, antigen-
primed CD4+ T cells exhibit different capacities to proliferate
in response to recall stimulation. We found that the differences
in the proliferative response of antigen-primed CD4+ T cells
to recall antigens was not due to TCR down-regulation as
CD4+ T cells from all the groups expressed similar level of
surface TCR (data not shown). All ex vivo antigen-primed
CD4+ T cells expressed different level of Ki-67, a marker
indicative of ongoing proliferation, which perhaps could
account for high background proliferative response. Data
presented here provide evidence that ex vivo PfMSP-119 and
PfAg-primed CD4+ T cells expressed low levels of Ki-67
reflecting an ongoing response that was initiated in vivo but
fail to undergo cell cycle progression after in vitro Ag re-
stimulation. The low proliferation of PfMSP-119 and PfAg
primed CD4+ T cells is possibly due to cell cycle arrest of CD4+
T cells. The failure of PfMSP-119 and PfAg-primed CD4
+ T cells
Figure 9 AICD of PfMSP-119 and PfMSP3 primed CD4
+ T cells is 
caspase dependent. A and B, CD4+ T cells from Ag primed mice 
were purified 7 days after last immunization and stimulated or not 
stimulated in vitro with 100 μg/mL of recall antigen plus splenic 
APC. pan-specific caspase inhibitor Z-VAD-fmk (50 μm), caspase 3 
inhibitor (z-DEVD-fmk, 50 μm), caspase 8 inhibitor (Z-IETD-fmk, 
50 μm), caspase 9 inhibitor (Z-LEHD-fmk, 50 μm), or no inhibitor 
were added at the beginning of the culture. (a) 72 h after 
stimulation, percentage of apoptotic cells among CD4+ T cells were 
detected by staining cells with Annexin V FITC and analysed by 
flow cytometry. Data from three experiments were pooled to obtain 
the mean ± SD. *, P < 0·05 significant difference between no 
inhibitor- and presence of inhibitor for each group indicated above 
the bars. (b) 72 h after stimulation, CD4+ T cells were assessed for 
caspase-8, caspase-9 and caspase-3-like activity by colourimetric 
enzyme assay using specific substrate (Ac-IETD-pNA, -Ac-LEHD-
pNA and Ac-DEVD-pNA) as described in Materials and Methods. 
Results are depicted as mean ± SE of three independent 
experiments. *, P < 0·05 significant difference between no inhibitor- 
and presence of inhibitor for each group indicated above the bars.
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to progress through cell cycle while still expressing activa-
tion phenotype could be related to the increased activation
induced cell death. The kinetics of cell cycle arrest and AICD
in PfMSP-119 and PfAg-primed CD4
+ T cells show that the
block in cell cycle progression is detected between 48 and 72 h
and maximal AICD between 72 and 96 h. Based on these
observations, we may conclude that cell cycle arrest perhaps
is the principal cause of PfMSP-119 and PfAg-primed CD4
+
T cells to become susceptible to AICD. The low in vitro recall
responses of PfMSP-119 and PfAg primed CD4 T cells are
consistent with published data (48). Quin et al. (48) had shown
that MSP-119 of the mouse malaria parasite Plasmodium
chabaudi chabaudi (AS) also stimulate a weak CD4 T cell
response when compared to the response to a more structurally
simple region of the molecule and they had attributed the low
response to processing within distinct MHC class II pathways.
In contrast, PfMSP-3 primed CD4+ T cells and also OVA-
primed CD4+ T cells did not show any impairment in the
ability to enter the cell cycle and expressed increased level of
Ki-67. PfMSP-3-activated CD4+ T cells underwent a burst
of proliferation that was followed by apoptosis. Together,
these findings indicate that PfMSP-3 does exert stimulatory
effects on CD4+ T cells and inhibits TCR-induced cell cycle
progression rather late after T cell activation. Indeed,
the increase in survival of PfMSP-3-primed CD4+ T cells is
probably due to the maintenance of the proliferative capacity
of these activated T cells. Activated T cells are programmed
to acquire susceptibility to apoptosis only after a given number
of cell divisions (49). Also mature T cells in the G1 phase of
the cell cycle are refractory to receptor-induced apoptosis,
whereas T cells that have progressed to the S phase are sus-
ceptible (50). Stimulation of proliferating T cells has been
shown to result in AICD (51). It is tempting to speculate that
AICD of PfMSP-3-primed CD4+ T cells is regulated in this
way so as to allow T cells to expand and perform their effector
functions, while at the same time ensuring homeostasis.
A major observation from this study is that splenic CD4+
T cells from primed mice show the phenotype and optimal
cell cycle progression of activated effector rather than rest-
ing memory CD4+ T cells. Since no proliferation is observed
in the absence of APC or by naïve CD4+ T cells suggests that
PfMSP-119 and PfMSP-3 and also crude parasite extract did
not have any mitogenic effect on CD4+ T cells.
The main objective of the study was to determine which
cell death pathways were operative in PfMSP-119 and PfMSP-
3-induced AICD of CD4+ T cells. Results presented in this
study demonstrate that PfSMP-119 and PfMSP-3 as well crude
P. falciparum antigen resulted in sequential T cell activation,
proliferation followed by cell death via AICD in a dose- and
time-dependent manner. AICD is one of the mechanisms for
eliminating clonally expanded antigen-specific T cells (52,53).
In this study we demonstrate that malaria Ag-reactive CD4+
Figure 10 Role of Fas.Fc in caspase-8, casapse-9 and caspase-3 
activities in PfMSP-119 and PfMSP-3 primed CD4
+ T cells. CD4+ 
T cells from Ag primed mice were purified 7 days after last 
immunization and stimulated or not stimulated in vitro with 
100 μg/mL of recall antigen plus splenic APC. Fas-Fc fusion 
proteins (1 μg/mL) and caspase inhibitor (50 μm) or inhibitors were 
added at the beginning of the culture and maintained throughout 
the culture. 72 h after stimulation, CD4+ T cells were assessed for 
caspase-8, caspase-9 and caspase-3-like activity by colourimetric 
enzyme assay using specific substrate (Ac-IETD-pNA, -Ac-LEHD-
pNA and Ac-DEVD-pNA) as described in Materials and Methods. 
Results are depicted as mean ± SE of three independent 
experiments. *, P < 0·001 significant difference between no inhibitor- 
and presence of inhibitor for each group indicated above the bars.
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T cells are susceptible to antigen-mediated AICD which is
consistent with the observations of previous studies indicat-
ing that CD4+ T cells from infected individuals readily undergo
apoptosis upon in vitro stimulation with parasite lysate (16,17).
Our results show that blood stage antigens, PfMSP-119 and
PfMSP-3 trigger different AICD pathways in antigen primed
CD4+ T cells. PfMSP-3 sensitizes CD4+ T cells toward CD95-
mediated, caspase-8-dependent cell death. PfMSP-3 primed
CD4+ T cells show significant up-regulation and persistent
expression of Fas and FasL and blocking Fas–FasL interac-
tions abrogated PfMSP-3-mediated AICD of CD4+ T cells.
Furthermore, our study provide evidence that the PfMSP-3-
induced AICD of CD4+ T cells is mediated by activation of
caspase-8 and caspase-3 that are central to death receptor
apoptosis signalling pathways (54). Interrupting Fas–FasL
interaction significantly blocked activation of caspase-8 and
caspase-3 and reduced the AICD of PfMSP-3-primed CD4+
T cells. These results suggest that death receptor signalling
play a predominant role in PfMSP-3 induced AICD of CD4+
T cells. Furthermore, and consistent with previous reports,
our studies indicate that the OVA also induced Fas-mediated
AICD in Ag-activated CD4+ T cells (55).
PfMSP-119- as well as PfAg-primed CD4
+ T cells are rel-
atively insensitive to Fas-mediated cell death since blocking
this pathway did not increase cell survival or prevent caspase
activation. Instead, our studies indicate that the AICD in
these activated cells may involve engagement of mitochondria
apoptosis signalling pathway. Both pro- and anti-apoptotic
members of the Bcl-2 protein family largely regulate the
mitochondrial death pathway (56). In many instances it has
been reported that Bax expression is up-regulated during
apoptosis in several types of cells, together with the decrease
of the Bcl-2 protein level (57). But it is the ratio rather than
expression level of individual anti- and pro-apoptotic protein
that appears to be an important determinant for apoptosis:
lower ratio favours cell survival, whereas higher Bax : Bcl-2
ratio promotes cell death in several cell types including CD4+
T cells (58). The expression profile of Bcl-2 and Bax expres-
sion in PfMSP-119- and PfAg-primed CD4
+ T cells suggests
that up-regulation of Bax protein and resulting change of
Bax : Bcl-2 protein ratio may be an important determinant
for the induction of AICD. The translocation of the pro-
apoptotic molecule Bax to mitochondria possibly mediated
the release of cytochrome c and regulated the intrinsic apop-
tosis pathway involving the mitochondria (59). Consistent
with this observation, Bax was found to be predominantly
associated with the mitochondrial fraction and cytochrome
c was predominantly detected in the cytosolic fraction of the
both PfMSP-119- and PfAg-activated CD4
+ T cells. Blocking
caspase-9 activation with a specific inhibitor, z-LEHD-fmk,
reduced both PfMSP-119 and PfAg induced AICD of Ag-
primed CD4+ T cells, further demonstrated that the mito-
chondrial cascade played a significant role in PfMSP-119-
and PfAg-induced apoptosis of the CD4+ T cells. Xu et al.
(42) had demonstrated that the depletion of parasite-specific
CD4+ T cells was independent of  TNF or Fas molecules
but the molecular mechanism was not established. Recently,
Guha et al. (60) had shown that mechanistic basis of hepatic
dysfunction during blood stage infection involves simultane-
ous Bcl-2 down-regulation and Bax up-regulation and reduced
the Bcl-2 : Bax ratio, resulting in the activation and transloca-
tion of Bax to mitochondria. Bax translocation to mitochon-
dria through opening of permeability transition pores induced
release of apoptotic inducing proteins, such as cytochrome
c into cytosol. Cytochrome c activates caspase-3, which
finally executed the apoptosis of hepatocytes. Thus, PfMSP-
119 and PfSMP-3 primed CD4
+ T cells appear to use distinct
mechanisms of AICD to limit excessive clonal expansion
following a productive response, while permitting important
effector functions to be expressed.
In this study, we demonstrate that different merozoite sur-
face antigens are capable of modulating not only the course
of CD4+ T cell activation but also trigger diverse apoptotic
programs of AICD; however, it is not clear what factors
determine these programs. Recently, it has been shown that
T cells from P. falciparum infected individuals are conditioned
in vivo to die by apoptosis in vitro (28–31). It is thus likely
that a major and universal mechanism of parasite-induced
immune suppression may be the stimulation of CD4+ T cells
into apoptotic death upon antigenic challenge. Although
apoptosis during malaria infection may help in attenuating
acute antiparasite responses, at the same time it may also
lead to defective immune responses and lead to unrestricted
parasitemia and damage of host tissues (41,42). The blood
stage parasite antigens that interact with the host cells’
apoptosis signalling cascades may have impact on the course
of disease. Thus, the current study could provide a model for
investigating the molecular mechanisms underlying the dele-
tion of whole parasite-specific proliferative CD4+ T cells and
develop strategies to enhance immunity following immuniza-
tion. The practical implication of predicting the effects of
various potential malaria vaccine candidates on the CD4+
T cell activation, proliferation and apoptosis will add to our
understanding the efficacy of  antigen(s) based malaria
vaccine development. These issues are of utmost importance
in malaria immunity and antigen(s) based malaria vaccine
development.
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